6 July 2005
Lawrence Kinet, Group Managing Director - Medical, steps down from that role today and assumes personal responsibility for the international marketing of the Smiths Medical diabetes product range. Mr Kinet leaves the Smiths Board with immediate effect.
Einar Lindh, who retired from the Smiths Board in January 2005, rejoins the company to lead Smiths Medical on an interim basis. Mr Lindh, whose distinguished career with Smiths included 12 years in senior roles within the Medical division, will report to Keith Butler-Wheelhouse, Chief Executive of Smiths Group.
Mr Butler-Wheelhouse said: "Lawrence has expressed a wish, as he approaches his planned retirement from Smiths, to concentrate on the 'Cozmo' product range which he was instrumental in launching. I am pleased that we are able to respond with this organisational change.
The search for Lawrences successor is already under way. Meanwhile we are very fortunate to have Einar Lindh available to us. Einars track record at Smiths Group, latterly as head of the Specialty Engineering division, is well known and his past experience within Medical will be invaluable. I look forward to working with Einar to secure the full potential of our Medical business."
The company will issue its normal year end trading statement in early August 2005.
ENDS
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths Group plc – Q1 Trading Update
Find out moreSmiths Detection supplies industry-leading 3D X-ray scanners to Kansai International Airport
Passengers passing through Osaka’s busiest airport will soon be able to leave liquids and electronics in bags.
Find out moreSmiths Detection receives key certification for its AI-powered threat detection technology
AI-empowered technology identifies a wide range of airport threats and meets strict EU and Dutch requirements, setting an industry benchmark
Find out more